Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2024 -0.972M
March 31, 2024 -4.642M
December 31, 2023 -1.911M
September 30, 2023 -5.749M
June 30, 2023 -5.904M
March 31, 2023 -10.35M
December 31, 2022 -13.09M
September 30, 2022 -11.07M
June 30, 2022 -20.40M
March 31, 2022 -17.04M
December 31, 2021 -18.34M
September 30, 2021 -10.51M
June 30, 2021 -8.894M
March 31, 2021 -11.25M
December 31, 2020 -3.329M
September 30, 2020 -4.18M
June 30, 2020 -6.981M
March 31, 2020 -6.423M
December 31, 2019 -5.118M
September 30, 2019 -2.91M
June 30, 2019 -3.337M
March 31, 2019 -7.94M
December 31, 2018 -6.942M
September 30, 2018 -0.544M
June 30, 2018 -0.332M
Date Value
March 31, 2018 -0.308M
December 31, 2017 -2.498M
September 30, 2017 -3.222M
June 30, 2017 -3.659M
March 31, 2017 -1.192M
December 31, 2016 -2.599M
September 30, 2016 -2.309M
June 30, 2016 -3.807M
March 31, 2016 -5.065M
December 31, 2015 -1.31M
September 30, 2015 -6.594M
June 30, 2015 -8.611M
March 31, 2015 -6.127M
December 31, 2014 -9.118M
September 30, 2014 -4.096M
June 30, 2014 -4.625M
March 31, 2014 -0.192M
December 31, 2013 0.95M
September 30, 2013 -4.357M
June 30, 2013 -5.685M
March 31, 2013 -6.011M
December 31, 2012
September 30, 2012 -2.897M
June 30, 2012 -3.590M
March 31, 2012 -5.159M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Filana Therapeutics, Inc. -3.855M
CorMedix, Inc. 86.06M
Eloxx Pharmaceuticals, Inc. -4.789M
Cannabis Global, Inc. -0.112M
BioStem Technologies, Inc. -5.538M